Zoplar, a platform focused on improving the medical equipment procurement process for small and medium-sized hospitals in India, has raised $3.4 million in a Series A funding round led by Blume Ventures.
The round also saw participation from Beenext, Saison Capital, Atrium Angels, Finfirst, and LogX Ventures.
The fresh funds will be used to bolster its operational capabilities, focusing on backward integration in the supply chain and the development of a robust service engineering team.
With this latest round, Zoplar has raised a total of $5.1 million in funding, with contributions from Titan Capital, Stride Ventures, and Panthera Peak.
Zoplar co-founders Amit Sah and Umesh Sharma said, “This investment is not just financial backing – it’s a validation of our mission to make quality healthcare accessible through affordable and reliable medical technologies. It motivates us to scale our impact, enhance our offerings, and continue empowering healthcare providers to deliver uninterrupted care.”
Sajith Pai, VC at Blume Ventures, the lead investor, added, “We believe in Zoplar’s vision and their potential to significantly impact the healthcare landscape in India. Their approach to improving medical equipment procurement and after-sales service is aligned with our focus on supporting ventures that drive societal change.”
Founded in 2022 by Amit Sah and Umesh Sharma, Zoplar is a full-stack medical equipment platform that aims to streamline the buying process and support the growing needs of India’s healthcare infrastructure.
Zoplar claimed to address key pain points faced by MSME hospitals, such as identifying price-optimal products, managing vendor relationships, ensuring quality after-sales service, and accessing financing solutions.
Zoplar said that it has already established momentum, partnering with around 300 hospitals, including major nephrology chains such as DCDC.
